[Media Releases] [LegoChem Biosciences] LegoChem wins 'BioSpectrim Asia Emerging Company of the Year 2012 Award'.

Title: LegoChem Biosciences– LegoChem won BioSpectrim Asia Emerging Company of the Year 2012 Award.

Publication: LegoChem Biosciences

Date: 17 March 2012

Summary

• LegoChem Biosciences (CEO Yong Zu Kim) won ‘BioSpectrum Asia Emerging Company of the Year 2012 Award' in The Fourth Biospectrum Asia Pacific Award, sponsored by international bio magazine BioSpectrum Asia.

To view the full article (in Korean), click here ▶

About LegoChem Biosciences

LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative medicines by leveraging our chemistry expertise to make conventional biologics targeted and more potent for the benefit of patients with diseases of high unmet medical needs. We are advancing sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).